Monthly Archives: October 2015

Key findings to develop a vaccine against Toxoplasma

Identified the role of an experimental pathogenic parasite toxoplasma-inactivated vaccine. …read more

By |October 30th, 2015|Uncategorized|0 Comments|

Towards a safe and efficient SARS-coronavirus vaccine: mechanism and prevention of genetic instability of a live attenuated virus

Live attenuated (weakened) viral vaccines are considered safe so long as their “reversal” to a virulent (or disease-causing) virus is prevented. …read more

By |October 29th, 2015|Uncategorized|0 Comments|

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

Between 17 and 24 October 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 12 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including 1 death. Contact tracing of household and healthcare contacts is ongoing for these cases. …read more

By |October 29th, 2015|Uncategorized|0 Comments|

NORD publishes guide to promote physician awareness of rare lung disorder

The National Organization for Rare Disorders (NORD) has published a Physician Guide to Nontuberculous Mycobacterial Lung Disease to promote awareness of this rare disorder among physicians and… …read more

By |October 29th, 2015|Uncategorized|0 Comments|

Bacterial hole puncher could be new broad-spectrum antibiotic

Bacteria have many methods of adapting to resist antibiotics, but a new class of spiral polypeptides developed at the University of Illinois targets one thing no bacterium can live without: an outer… …read more

By |October 29th, 2015|Uncategorized|0 Comments|